1. Al-Shami A, Crisostomo J, Wilkins C, Xu N, Humphries J, Chang WC, Anderson SJ, Oravecz T. 2013. Integrin-α FG-GAP Repeat-Containing Protein 2 is critical for normal B cell differentiation and controls disease development in a lupus model. J Immunol. 191(7):3789-98. Epub 2013 Aug 30. PMID: 23997217.
  2. Lee SY, Rao S, Gutierrez A, Perrigoue J, Thapa R, Tu Z, Jeffers JR, Rhodes M, Anderson SJ, Oravecz T, Hunger SP, Timakhov R, Balachandran S, Zambetti GP, Testa JR, Look AT, and Wiest DL. 2012. Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.  Blood. In Press.
  3. Stadanlick JE, Zhang Z, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL. Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors. J Immunol. 2011. Jul 15;187(2):664-75. Epub 2011 Jun 20. PubMed PMID: 21690328; PubMed Central PMCID: PMC3131471.
  4. Al-Shami A, Jhaver KG, Vogel P, Wilkins C, Humphries J, Davis JJ, Xu N, Potter DG, Gerhardt B, Mullinax R, Shirley CR, Anderson SJ, Oravecz T. Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development. PLoS One. 2010. Oct 27;5(10):e13654. PubMed PMID: 21048919; PubMed Central PMCID: PMC2965108.
  5. Al-Shami A, Wilkins C, Crisostomo J, Seshasayee D, Martin F, Xu N, Suwanichkul A, Anderson SJ, Oravecz T. The adaptor protein Sh2d3c is critical for marginal zone B cell development and function. J Immunol. 2010. Jul 1;185(1):327-34. Epub 2010 May 26. PubMed PMID: 20505138.
  6. Vogel P, Donoviel MS, Read R, Hansen GM, Hazlewood J, Anderson SJ, Sun W, Swaffield J, Oravecz T. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS One. 2009;4(1):e4112. Epub 2009 Jan 1. PubMed PMID: 19119317; PubMed Central PMCID: PMC2606024.
  7. Jessop TC, Tarver JE, Carlsen M, Xu A, Healy JP, Heim-Riether A, Fu Q, Taylor JA, Augeri DJ, Shen M, Stouch TR, Swanson RV, Tari LW, Hunter M, Hoffman I, Keyes PE, Yu XC, Miranda M, Liu Q, Swaffield JC, David Kimball S, Nouraldeen A, Wilson AG, Foushee AM, Jhaver K, Finch R, Anderson S, Oravecz T, Carson KG. Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6784-7. Epub 2009 Sep 25. PubMed PMID: 19836232.
  8. Tarver JE, Jessop TC, Carlsen M, Augeri DJ, Fu Q, Healy JP, Heim-Riether A, Xu A, Taylor JA, Shen M, Keyes PE, David Kimball S, Yu XC, Miranda M, Liu Q, Swaffield JC, Nouraldeen A, Wilson AG, Finch R, Jhaver K, Foushee AM, Anderson S, Oravecz T, Carson KG. 5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6780-3. Epub 2009 Sep 25. PubMed PMID: 19836229.
  9. Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA, Gerhardt B, Hardy RR, Oravecz T, Wiest DL. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity. 2007 Jun;26(6):759-72. Epub 2007 Jun 7. PubMed PMID: 17555992.
  10. Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell. 2003 Nov;4(5):349-60. PubMed PMID: 14667502.
  11. Creson JR, Lin AA, Li Q, Broad DF, Roberts MR, Anderson SJ. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro. J Virol. 1999 Nov;73(11):9337-47. PubMed PMID: 10516042; PubMed Central PMCID: PMC112968.
  12. Luo T, Anderson SJ, Garcia JV. Inhibition of Nef- and phorbol ester-induced CD4 degradation by macrolide antibiotics. J Virol. 1996 Mar;70(3):1527-34. PubMed PMID: 8627671; PubMed Central PMCID: PMC189974.
  13. Foster JL, Anderson SJ, Frazier AL, Garcia JV. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open. Virology. 1994 Jun;201(2):373-9. PubMed PMID: 8184546.
  14. Anderson SJ, Lenburg M, Landau NR, Garcia JV. The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef. J Virol. 1994 May;68(5):3092-101. Erratum in: J Virol 1994 Jul;68(7):4705. PubMed PMID: 8151774; PubMed Central PMCID: PMC236799.
  15. Anderson SJ, Coleclough C. Regulation of CD4 and CD8 expression on mouse T cells. Active removal from the cell surface by two mechanisms. J Immunol. 1993 Nov 15;151(10):5123-34. PubMed PMID: 8228214.
  16. Moore SC, Anderson SJ, Walker WS. Mouse macrophages contain a truncated CD4 transcript. J Leukoc Biol. 1992 Jul;52(1):128-9. PubMed PMID: 1640169.
  17. Anderson SJ, Hummell DS, Lawton AR. Differentiation of human B lymphocyte subpopulations induced by an alloreactive helper T-cell clone. J Clin Immunol. 1988 Jul;8(4):275-84. PubMed PMID: 2970473.
  18. Anderson SJ, Lawton AR. LPS augments human B-cell differentiation by direct stimulation of PWM-responsive B cells. Clin Immunol Immunopathol. 1987 Sep;44(3):259-71. PubMed PMID: 3497745.
  19. Hummell DS, Anderson SJ, Wright PF, Cassell GH, Waites KB. Chronic recurrent multifocal osteomyelitis: are mycoplasmas involved? N Engl J Med. 1987 Aug 20;317(8):510-1. PubMed PMID: 3614302.